Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion

被引:0
作者
Yu Zhang [1 ]
Li-Ke Yu [1 ]
Ning Xia [1 ]
机构
[1] Department of Respiration,Nanjing Chest Hospital
关键词
Pleural effusion; Serum; Endostatin; Lung cancer; Vascular endothelial growth factor;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
Objective:To evaluate the diagnostic value of endostatin(ES),vascular endothelial growth factor (VEGF) and careinoembryonie antigen(CEA) in both serum and pleural effusion of lung cancer patients.Methods:Levels of ES,VEGF and CEA in 52 malignant pleural effusion due to lung cancer and 50 patients with non-malignant disease were measured by using sandwich enzymelinked immunosorbent assay and microparticle enzyme immunoassay.Results:The ES.VEGF and CEA levels in pleural effusion and serum,and their ratio(F/S) were higher in lung cancer group than that in benign group,and the differences were statistically significant(P<0.05).The diagnostic efficiency of ES+VEGF for lung cancer was superior to either single detection.The diagnostic efficiency of ES+VEGK+CEA was superior to either ES+VEGF or ES+CEA.Conclusions: The results suggest that ES,VEGF and CEA might be useful in the differentiation between benign and malignant pleural effusion due to lung cancer.In comparison with either single determination of concentration in serum or pleural fluid,the couiljined detection of two or three markers is of important clinical significance in the diagnosis of lung cancer.
引用
收藏
页码:239 / 242
页数:4
相关论文
共 5 条
  • [1] 血清内皮抑素水平在肺癌早期诊断中应用研究
    程梅莲
    刘峰
    李小琴
    [J]. 国际检验医学杂志, 2009, 30 (01) : 39 - 40
  • [2] The use of endostatin in the treatment of solid tumors
    Karamouzis, Michalis V.
    Moschos, Stergios J.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (05) : 641 - 648
  • [3] Vascular endothelial growth factor: the key mediator in pleural effusion formation[J] . Carolyn S. Grove,Y.C. Gary Lee.Current Opinion in Pulmonary Medicine . 2002 (4)
  • [4] Serum endostatin correlates with progression and prognosis of non-small cell lung cancer
    Suzuki, M
    Iizasa, T
    Ko, E
    Baba, M
    Saitoh, Y
    Shibuya, K
    Sekine, Y
    Yoshida, S
    Hiroshima, K
    Fujisawa, T
    [J]. LUNG CANCER, 2002, 35 (01) : 29 - 34
  • [5] Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth[J] . Michael S O’Reilly,Thomas Boehm,Yuen Shing,Naomi Fukai,George Vasios,William S Lane,Evelyn Flynn,James R Birkhead,Bjorn R Olsen,Judah Folkman.Cell . 1997 (2)